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INTRODUCTION
Ventricular septal defects (VSDs) are the most common congenital heart disorders, accounting for 20-30% of all congenital cardiac malformations [1] and leading to early disability in the paediatric age group. Treatment is required when the defect results in symptoms of heart failure or when left heart chamber overload is detected on echocardiography [2] .
Conventional surgical VSD repair is considered as the 'gold standard' treatment; however, it is associated with the potential complications of cardiopulmonary bypass (CPB), a risk of bleeding, surgical trauma, and poor cosmetic results. To reduce the impact of such drawbacks, interventional VSD closure with transfemoral occlusive devices has been proposed as an alternative method. Nevertheless, it is a complex implantation technique with an unacceptable high rate of postprocedural heart block (2.9-5.7%) and interference with the aortic and tricuspid valves [2, 3] . Off-pump perventricular device closure (PVDC) of VSD under echocardiographic guidance through a minimally invasive approach is increasingly used. According to the literature, the PVDC procedure is highly effective and safe, has no cut-off age requirement, and provides excellent immediate and long-term results [4] [5] [6] . However, there have been no prospective randomized studies on PVDC. The aim of our study was to compare the results of the conventional approach (CA) with those of PVDC for VSD repair.
MATERIALS AND METHODS

Patient population
Between June 2012 and August 2014, 640 consecutive patients with isolated VSD (or residual VSD after a previous repair) were enrolled in the study (Fig. 1 ). This was a prospective, open and †Presented at the 29th Annual Meeting of the European Association for Cardio-Thoracic Surgery, Amsterdam, Netherlands, 3-7 October 2015. randomized study with 2 arms. The study was approved by the local ethics committee and was conducted in compliance with the protocol, following standard operating procedures. All patients signed an informed consent form before participation. The present study was conducted in compliance with the Declaration of Helsinki. The patients' baseline characteristics are given in Table 1 . The indications for the surgery were a VSD of >5 mm in patients aged from 0 to 3 years, with a pulmonary/systemic blood flow of >1.5, and/or evidence of heart failure. In patients older than 3 years, the indications were VSD >3 mm, pulmonary/ systemic blood flow ratio >1.5, and/or evidence of heart failure.
Enrolment protocol
Inclusion criteria
• Patients with congenital isolated VSD (perimembranous, subarterial, muscular) scheduled for surgery; • Patients with residual VSD post-surgical repair of a congenital VSD.
Exclusion criteria
• Patients with congenital heart disease scheduled to be operated concomitantly with CPB; The patients were randomly assigned to either treatment with PVDC (PVDC group; n = 320) or VSD repair with the CA (CA group; n = 320), by using computer-generated randomization.
Follow-up protocol
Follow-up examinations were performed at 3, 6, 12, and 24 months, including routine electrocardiography to detect arrhythmias and atrioventricular (AV) conduction disturbances; transthoracic echocardiography to assess the device position, residual shunts, tricuspid and aortic valve competence; blood and urine tests to determine haemolysis. Data were available for all patients in both groups. 
Conventional ventricular septal defect closure
All patients in the CA group were operated through a median sternotomy approach, under normothermia and standard CPB with bicaval cannulation. Cold crystalloid cardioplegia (Custadiol; Dr Kohler Pharma, Alsbach-Hahnlein, Germany) was used for myocardial protection in all cases. VSD closure was performed through a right transatrial access, by using a diepoxy-treated xeno-pericardial patch with a continuous running 6/0 polypropylene suture. Transoesophageal echocardiography (TEE) was used in all cases to assess tricuspid and aortic valve competence, as well as the residual shunts.
Perventricular ventricular septal defect closure
All patients were placed in the supine position and procedures were done under general anaesthesia. A 3-cm skin incision was made in the lower third of the sternum; the xiphoid process was divided into 2; and a small rib spread retractor was applied. The pericardium was opened to expose the right ventricle (RV), and systemic heparin (1 mg/kg) was administered. To determine the puncture site, the free RV wall was palpated lightly to locate the area of maximal trill, corresponding to the VSD location. A purse-string suture was placed on the RV free wall at the point of maximal trill. After the RV puncture, a guidewire was inserted through a needle into the left ventricle via the VSD under TEE guidance, and the delivery sheath was passed into the defect (Fig. 2C) . A second sheath with the VSD occlusion device (MemoPart VSD Occlusion Device; Lepu Medical Technology, Shanghai Shape Memory Alloy Co., Ltd., Shanghai, China) was inserted through the defect into it and pulled it back until both discs were completely open. The chest wall was closed in a routine manner. TEE was used in all cases during the entire procedure to guide and check the device position, to evaluate tricuspid and aortic valve insufficiency and leaflet motion, and to detect residual shunts.
In patients with re-VSD who had previously undergone VSD repair with CA, we performed a full, rather than a partial, resternotomy. Nevertheless, the PVDC procedure required cardiolysis of only the anterior RV wall.
Devices and delivery systems
The device size was chosen according to the position and diameter of the VSD, and the thickness of the interventricular septum. Four different Lepu medical occluders (MemoPart VSD Occlusion Device; Lepu Medical Technology, Shanghai Shape Memory Alloy Co., Ltd., Shanghai, China) were used, as follows:
• SQFDQ I-a 'muscular' VSD occluder with longer waist (up to 10 mm). This was used in 6 (1.9%) cases. It is designed for interventricular septum >5 mm. We used a 2-mm oversize for this occluder type.
• SQFDQ II-a 'perimembranous' VSD occluder that is a symmetric device. This was the most commonly used device [in 215 (67.2%) patients]. We routinely use this type in cases with sufficient perimembranous VSD rims and in cases of muscular VSD if the thickness of the interventricular septum is < 5 mm (usually in small babies <5.0 kg) (Fig. 2B ).
• SQFDQ III-an 'aneurysmatic' VSD occluder that is a nonsymmetrical device. This device has a big left disc and was used in 25 (7.8%) patients. It is specially developed for VSD or VSDs localized in the aneurysmatic part of the interventricular septum.
• SQFDQ IV-a 'subaortic' VSD occluder type that is an eccentric device ('zero ring' type) with a significantly reduced (to 0.5 mm) upper rim of the left disc. It was used in 74 (23.1%) patients with an aortic rim length of <1-2 mm ( Fig. 2A ). All devices were made of 0.004-in nitinol wire filled with medical felt. The occluder size ranged from 3 to 11 mm, with the delivery sheath size depending on the device size (7F, 8F, or 9F).
Statistical analysis
The sample size calculation was based on an 8.1% expected difference [7] in mean deposition for a statistical power of 80%, and conducted with the application G*Power 3.1 (http://gpower.hhu.de). The calculated sample size was increased by 10% owing to the compensation effect of incomplete observations in the follow-up period. Continuous variables are expressed as median (25th; 75th percentile), unless otherwise specified. Categorical variables are presented as numbers (%). The Mann-Whitney, chi-square, and Fisher tests were used for inter-group comparisons. Multiple logistic regression analysis was performed to detect risk factors for the occurrence of complications (residual shunts). The multivariate model considered the significant variables (P < 0.05) in univariate analysis, and odds ratios and their 95% confidence intervals were calculated. P < 0.05 was considered statistically significant. Statistical analysis was performed by 
RESULTS
Intraoperative data
The average procedure time was significantly longer in the CA group than in the PVDC group ( Table 2 ). The success rate of the procedure was 96.6% in the PVDC group; 11 patients (3.4%) were converted to conventional surgery. In 1 (0.3%) patient, the procedure failed because complete AV block occurred just after the left disc of the occluder had been opened; normal conduction was restored after the conventional procedure. Another reason for conversion was a >3 mm residual shunt in 6 (1.9%) patients. In addition, in 4 (1.3%) patients, the occluder size did not accurately match the VSD diameter and the occluder migrated to the right chamber. All cases of PVDC procedural failure were immediately converted to CA.
There were no patients with complete AV block in either group. Transient AV block was observed in 6 cases in the CA group immediately after the procedure and in 2 patients in the PVDC group, at 4 and 7 days after the operation (P = 0.185). Normal AV conduction was completely restored after a short course of corticosteroid therapy. None of these patients required permanent pacemaker implantation.
The average intraoperative blood loss was 27.6 (10; 30) ml in the PVDC group and 38 (20; 60) ml in the CA group (P = 0.015). The mean duration of stay in the intensive care unit (ICU) was significantly longer in the CA group. Most of the patients in the PVDC group were extubated in the operating room or within 2 h after ICU admission (Table 2) . Intraoperative transfusion of blood products was needed in 285 (86.1%) cases (all patients weighing <20 kg) in the CA group because of CPB priming, and in none of the patients in the PVDC group (P < 0.001). Thirteen (3.9%) patients in the CA group and only 4 (1.3%) patients in the PVDC group required postoperative blood transfusion in the ICU (P = 0.040).
During the early postoperative period, 1 (0.3%) patient in the CA group and 3 (1.0%) patients in the PVDC group required pericardiocentesis because of significant pericardial effusion (P = 0.284). Echocardiography at discharge revealed that 34 (10.3%) patients in the CA group and 17 (5.5%) patients in the PVDC group had a trivial (<2 mm) residual shunt (P = 0.026). No new AV or aortic insufficiency, or obstruction of either ventricular outflow tract was seen in either group. Pulmonary artery pressure was significantly reduced in both groups on the discharge echocardiogram in comparison with the preoperative data: from 35.9 (30; 40) to 23.9 (23; 31) mmHg in the PVDC group (P < 0.001), and from 36.1 (31; 48) to 24.4 (25; 34) mmHg in the CA group (P < 0.001); the difference between groups was not statistically significant (P = 0.418).
Follow-up
The mean follow-up duration was 24.6 ± 1.7 and 25.1 ± 2.1 months in the PVDC and CA groups, respectively (P = 0.674), and complete follow-up was achieved in all patients. No late deaths occurred in either group. There were significantly more residual shunts in the CA group, both in the early postoperative period and at the last follow-up, when the transthoracic echocardiographic examination showed that some shunts had closed spontaneously without the appearance of new shunts (Fig. 3) . Multivariate risk factor analysis revealed that the technique (CA), patient age, and VSD size were independent predictors of residual shunts (Table 3) .
We found no rhythm or conduction disorders in any patients. There were no patients with endocarditis in both groups, and we did not detect any device dislocation or obstruction of the outflow tracts (left or right) in the PVDC group.
No sternum or rib deformation was observed, and the small skin incision showed excellent cosmetic result in the PVDC group. No patient in either group had an indication for reoperation (Table 4) .
DISCUSSION
It has been half a century since the first VSD repair was reported by Lillehei et al. [8] with cross-circulation, and by Donald et al. [9] , using CPB. The next significant step in the treatment of patients with VSD was the use of transcatheter technology for VSD closure. This technique overcomes the disadvantages of CPB, the postoperative pain, the potential risk of mediastinitis, and the cosmetic defects. On the other hand, interventional closure through the femoral route depends on vascular access and is accompanied by a high risk of disturbances of AV conduction in young children.
In 1998, Amin and colleagues proposed the technique of PVDC for VSD closure in experimental animal models without CPB support, by using a special device under echocardiographic guidance. Such a 'transventricular model' of VSD closure was first successfully applied in children with muscular VSD in 2003, and subsequently for perimembranous VSD by Xing et al. [10] [11] [12] .
In contrast with the transcatheter femoral VSD closure technique, the advantages of the PVDC procedure are obvious. The PVDC procedure is not restricted by the patient's weight and age without risk of femoral artery injury from guidewire and sheath insertion. The PVDC system delivers the device to the defect via a short and direct path. The length of the guide system inserted through the free wall of the RV does not exceed 5 cm (the distance to the left ventricular chamber), which allows precise device opening and, in most cases, avoids involvement of the surrounding anatomical structures. On the other hand, we concur that percutaneous VSD closure is a less invasive procedure without any surgical scar. Nevertheless, both procedures (transfemoral and perventricular) are performed under general anaesthesia, and use radiation and contrast load in transfemoral cases.
Some published studies have compared the PVDC technique with conventional VSD surgical treatment; however, they were limited by their retrospective design, with no statistical matching between groups [7, 13, 14] . Our study is the first prospective randomized study to compare the conventional surgical approach with the PVDC technique for VSD repair.
Complete atrioventricular block
One of the most serious complications after VSD closure is complete AV block, which occurs in 1-5% of patients who undergo conventional surgical repair [5, 7] . The incidence of complete AV block after femoral transcatheter device closure is rather controversial, with reports ranging from 0% to 8.7% [3, 4, 15] . One randomized study that compared femoral transcatheter device closure with conventional surgery reported that there was no complete AV block in either group; however, all patients were older than 3 years. The European Registry of transcatheter closure of congenital VSDs [3] reported that 9 of 16 patients with complete AV block were under 3 years old. An analysis of the risk factors for the occurrence of complications based on this registry showed that age and weight were significant predictors of early complications [3] . According to literature data, the incidence of complete AV block after PVDC does not exceed 1% [10, 16] . In our study, only 1 (0.3%) patient in the PVDC group developed complete AV block, and no case of complete AV block was observed among patients in the CA group. It should be noted that >80% of our patients were under 3 years old and weighed <10 kg.
In cases of disturbances in AV conductance during guiding system delivery or device opening, we recommend removing the device immediately and repeating the manipulation after conduction has been restored. For similar conduction problems, we performed conversion to conventional VSD closure. When AV block occurred in the early postoperative period, we used a short course of corticosteroid therapy, with positive results in all of our cases. However, Ovaert et al. [17] reported that in 2 of their cases, removal of the surgical device some days after the transfemoral transcatheter procedure induced normal AV conduction.
Valve incompetence
Incorrect selection of the size and type of the occluder, and errors in positioning the device in the VSD can lead to dysfunction of the AV and aortic valves. Suture-related injury of the aortic valve with significant insufficiency rarely occurs after conventional VSD repair. Some authors reported procedureinduced trivial or mild tricuspid (3.3-6%) or aortic (3.3-21.3%) regurgitation; however, these needed no treatment [2, 3, 18] . Postoperative trivial tricuspid valve regurgitation has been reported in as many as 36% of patients after a conventional surgical repair procedure [19] . In our study, we did not observe any newonset valve insufficiency after either the conventional or perventricular procedure. However, we believe that the appearance of new aortic jets and increasing regurgitation during implantation are strong indications for converting to CA. Precise attention is required in patients with subaortic VSD localization. Assessing aortic annulus and right cusp deformation by using intraoperative TEE is absolutely necessary, even in cases without aortic regurgitation. Excellent visualization of the tricuspid valve structure under intraoperative TEE guidance is a key to procedural success. Moreover, a direct pathway of the guidewire in cases of the perventricular approach without any wire loop creation through the heart and the VSD allows avoiding damage of the septal cusp. To prevent tricuspid valve involvement, we avoid device closure in patients with subvalvular structures attached to the VSD rim. Nevertheless, for cases with more than mild tricuspid valve insufficiency, we perform conversion to CA.
Residual shunts
Residual shunts are frequently observed after VSD repair through either a CA or a transcatheter procedure. Some authors have reported rates of trivial residual shunts rate ranging from 6.4% to 39% for CA [5, 16, 18] . The incidence of residual shunts in patients undergoing PVDC is approximately 2.6-4% [16, 18] . In our study, the largest number of shunts was detected at the end of the procedure, with a decrease during the follow-up period; this is consistent with reports in the literature [5] . We observed a significantly smaller number of residual shunts in patients in the PVDC group than in those in the CA group. However, in 2.5% of patients, the reason for conversion was haemodynamically significant residual flow at the occlude rim. Most of the marginal shunts were <3 mm and all intradisc shunts spontaneously closed during the first follow-up year. A residual shunt of >3 mm was considered to be an indication for conversion to the conventional procedure. We suppose that the higher incidence of residual shunts in the CA group might be due to our technique-continuous running suture instead of U-like stitches. Our hypothesis about the correlation between patient age and the incidence of shunts was based on the presence of unformed fibrous VSD margins in babies under 1 year old.
Pericardial effusion
Pericardial effusion occurs in 85% of patients after open-heart surgery [20] . Most of these effusions disappear spontaneously and require only drug therapy. However, 5% of patients have a clinically significant effusion that requires pericardiocentesis. It was notable that we found no significant differences in pericardial effusion between the 2 groups of patients, although patients in the CA group were treated via a full sternotomy approach with CPB, whereas the other group underwent only partial sternotomy and off-pump VSD closure.
Study limitations
We acknowledge that our mean follow-up period of 24 months is too short, and long-term results are needed. In addition, although our study was randomized, it represents only a single-centre experience.
CONCLUSION
PVDC of VSD is a safe and easily reproducible technique that is acceptable in patients of any age, and suitable for the most anatomical localization. Compared with CA, it is less traumatic, reduces the operation time and ICU and hospital stays, and provides excellent cosmetic results.
